Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing.
Journal Information
Full Title: Therap Adv Gastroenterol
Abbreviation: Therap Adv Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"All the authors declare that they have received fees for the articles, consultancies, research, or other collaborations from the following laboratories: MSD, Abbvie, Pfizer, Takeda, Janssen, Galapagos, Kern Pharma, Amgen, and Sandoz."
"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025